Determination of Parathyroid Function by Fluorescence With Indocyanine Green (ICG) After Total Thyroidectomy

Sponsor
Hospital Son Espases (Other)
Overall Status
Unknown status
CT.gov ID
NCT04012476
Collaborator
Universitat de les Illes Balears (Other)
40
1
1
47
0.9

Study Details

Study Description

Brief Summary

The intensity of parathyroid fluorescence that occurs after intravenous injection of indocyanine green during the performance of a total thyroidectomy correlates with postoperative parathyroid function and could be used as a diagnostic marker of postoperative hypoparathyroidism and hypocalcemia.

Condition or Disease Intervention/Treatment Phase
  • Drug: Indocyanine Green
Phase 4

Detailed Description

The main objective of the study is to compare the intensity of parathyroid fluorescence among patients who present post-thyroidectomy hypocalcemia with that of patients who do not have it. Therefore, the following points will be studied:

  • To study the correlation between parathyroid vascularization (intraoperative fluorescence intensity) and postoperative glandular function (serum calcium and parathormone levels).

  • To compare the surgeon's subjective assessment of parathyroid fluorescence in the groups of patients with and without postoperative hypocalcemia.

  • To compare the objective assessment of parathyroid fluorescence, by using specific computer software developed ad hoc, in the groups of patients with and without postoperative hypocalcemia.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Single group: patients undergoing total thyroidectomy with intraoperative infusion of intravenous indocyanine green A prospective unicentric and open clinical trial in which the fluorescence intensity of the parathyroid glands after indocyanine administration will be compared between two groups of patients: those with post-thyroidectomy hypocalcemia and patients who do not present it.Single group: patients undergoing total thyroidectomy with intraoperative infusion of intravenous indocyanine green A prospective unicentric and open clinical trial in which the fluorescence intensity of the parathyroid glands after indocyanine administration will be compared between two groups of patients: those with post-thyroidectomy hypocalcemia and patients who do not present it.
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Determination of Parathyroid Function by Fluorescence With Indocyanine Green (ICG) After Total Thyroidectomy
Actual Study Start Date :
Nov 1, 2016
Anticipated Primary Completion Date :
Mar 1, 2020
Anticipated Study Completion Date :
Oct 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: ICG

Patients undergoing total thyroidectomy with visualization of the parathyroid glands under infrared light after intraoperative intravenous injection of 5 mg of indocyanine green

Drug: Indocyanine Green
Administration of 5 mg of intravenous indocyanine green after total thyroidectomy for measurement of parathyroid fluorescence under infrared light
Other Names:
  • ICG
  • Outcome Measures

    Primary Outcome Measures

    1. Calcemia [Day 1 after surgery]

      Serum calcium level at 24 hours postoperatively

    2. Subjective parathyroid fluorescence [Intraoperatively]

      Fluorescence intensity of the parathyroid glands after administration of indocyanine green (ICG), measured on a subjective analogue scale (0: no fluorescence, 1: hypofluorescence or heterogeneous fluorescence, 2: homogeneous hyperfluorescence).

    3. Objective parathyroid fluorescence [Intraoperatively]

      Fluorescence intensity of the parathyroid glands after administration of indocyanine green (ICG), measured by specific computer software developed ad hoc.

    Secondary Outcome Measures

    1. Age [Baseline]

      Patient's age

    2. Sex [Baseline]

      Patient's gender

    3. Body mass index [Baseline]

      Patient's BMI

    4. Surgery date [Baseline]

      Day when surgery takes place

    5. Preoperative diagnosis [Baseline]

      Thyroid pathology indicating total thyroidectomy (thyroid carcinoma, atypical of uncertain significance, goiter or lymphocytic thyroiditis)

    6. Vitamin D [Preoperative blood test]

      Preoperative vitamin D level

    7. PTH preop [Immediately before surgery]

      Preoperative PTH level

    8. PTH 10 min [10 minutes post-thyroidectomy]

      PTH levels 10 minutes post-thyroidectomy

    9. Surgery [Inmediately after surgery]

      Scope of surgery: total thyroidectomy (TT), TT with central neck dissection, or TT with functional lateral neck dissection

    10. Time [Inmediately after surgery]

      Duration of surgery

    11. Parathyroid glands [During surgery]

      Number of parathyroid glands located during surgery,

    12. Parathyroid gland location [During surgery]

      Location of the parathyroid glands (superior right, inf-right, sup-left, inf-left).

    13. Pathologic result [during the first month after surgery]

      Outcome of thyroid pathology (papillary carcinoma, nodular hyperplasia or lymphocytic thyroiditis)

    14. Thyroid weight [during the first month after surgery]

      Thyroid weight

    15. PG in piece [during the first month after surgery]

      Presence of parathyroid glands in the surgical piece and number

    16. Stay [During the first month after surgery]

      Number of days of postoperative hospital stay until the day of hospital discharge, measured as full days of 24 hours

    17. Drain [Inmediately after surgery]

      Presence and number of surgical drainages

    18. PTH day 1 [Day 1 after surgery]

      PTH levels in the postoperative follow-up,

    19. Complications [During the first month after surgery]

      Emergence of postoperative complications.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients who are going to undergo total thyroidectomy, with or without cervical lymph node dissection.

    • Visualization of 2 or more parathyroid glands during the surgical act.

    • Normal renal and hepatic functions.

    • Absence of a history of hypersensitivity reactions to iodine or indocyanine green.

    • Able to understand the nature and protocol of the study and its procedures

    • Willingness to participate with the subsequent signing of informed consent.

    Exclusion Criteria:
    • Age <18 years

    • Hepatic or renal insufficiency

    • Hypersensitivity to iodine or to indocyanine green.

    • Pregnancy or lactation

    • Inability to understand the nature and procedures of the study.

    • Patients with known preoperative hyperparathyroidism.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital Universitari Son Espases Palma De Mallorca Illes Balears Spain 07120

    Sponsors and Collaborators

    • Hospital Son Espases
    • Universitat de les Illes Balears

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Hospital Son Espases
    ClinicalTrials.gov Identifier:
    NCT04012476
    Other Study ID Numbers:
    • ICG-Parathyroid
    First Posted:
    Jul 9, 2019
    Last Update Posted:
    Jul 9, 2019
    Last Verified:
    Jul 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Hospital Son Espases
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 9, 2019